• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchApogee Therapeutics
    Picture of Apogee Therapeutics logo

    APGE — Apogee Therapeutics News Story

    $135.070.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    • Market Cap
      $8.40bn
    • Enterprise Value
      $7.43bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • APGE Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    APGE Dividends
    All News

    NASDAQ RESUMED AT 07:20 AM

    Picture of Apogee Therapeutics logoApogee Therapeutics
    22/06/2026 12:20
    NASDAQ RESUMED  AT 07:20 AM

    Recent news on Apogee Therapeutics

    See all news
    • NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM

      03/09/2026 08:58
    • NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM

      03/09/2026 24:50
    • Brief: Abbvie Seeks At Least $8 Billion In Debt To Fund Apogee Deal - Bloomberg News

      04/08/2026 14:18
    • Street View: Strength in AbbVie's immunology pipeline to support revenue growth

      03/08/2026 12:32
    • AbbVie trims 2026 profit view on Apogee deal, tops second-quarter estimates (updated)

      31/07/2026 12:54

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.